Screening and Evaluation of Small Organic Molecules As ClpB Inhibitors and Potential Antimicrobials
Overview
Authors
Affiliations
Inhibition of ClpB, the bacterial representative of the heat-shock protein 100 family that is associated with virulence of several pathogens, could be an effective strategy to develop new antimicrobial agents. Using a high-throughput screening method, we have identified several compounds that bind to different conformations of ClpB and analyzed their effect on the ATPase and chaperone activities of the protein. Two of them inhibit these functional properties as well as the growth of Gram negative bacteria (E. coli), displaying antimicrobial activity under thermal or oxidative stress conditions. This activity is abolished upon deletion of ClpB, indicating that the action of these compounds is related to the stress cellular response in which ClpB is involved. Moreover, their moderate toxicity in human cell lines suggests that they might provide promising leads against bacterial growth.
Deciphering the mechanism and function of Hsp100 unfoldases from protein structure.
Lee G, Kim R, Lee S, Lee S, Tsai F Biochem Soc Trans. 2022; 50(6):1725-1736.
PMID: 36454589 PMC: 9784670. DOI: 10.1042/BST20220590.
Hsp100 Molecular Chaperone ClpB and Its Role in Virulence of Bacterial Pathogens.
Kedzierska-Mieszkowska S, Zolkiewski M Int J Mol Sci. 2021; 22(10).
PMID: 34070174 PMC: 8158500. DOI: 10.3390/ijms22105319.
The Role of ClpB in Bacterial Stress Responses and Virulence.
Alam A, Broms J, Kumar R, Sjostedt A Front Mol Biosci. 2021; 8:668910.
PMID: 33968993 PMC: 8100447. DOI: 10.3389/fmolb.2021.668910.
Repurposing p97 inhibitors for chemical modulation of the bacterial ClpB-DnaK bichaperone system.
Glaza P, Ranaweera C, Shiva S, Roy A, Geisbrecht B, Schoenen F J Biol Chem. 2020; 296:100079.
PMID: 33187983 PMC: 7948422. DOI: 10.1074/jbc.RA120.015413.
Targeting Mitochondrial Structure Sensitizes Acute Myeloid Leukemia to Venetoclax Treatment.
Chen X, Glytsou C, Zhou H, Narang S, Reyna D, Lopez A Cancer Discov. 2019; 9(7):890-909.
PMID: 31048321 PMC: 6606342. DOI: 10.1158/2159-8290.CD-19-0117.